1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Bolin, K.A. Anderson, D.J. Trulson, J.A. Thompson, D.A. Wilken, J. Kent, S.B.H. Millhauser, G.L. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking NE FEBS Lett. FEBLAL 0165 0014-5793 451 125 131 10.1016/S0014-5793(99)00553-0 10371151 NMR structure of a minimized human agouti related protein prepared by total chemical synthesis. 1999 US Mol.Endocrinol. MOENEN 2068 0888-8809 13 148 155 10.1210/me.13.1.148 Characterization of Agouti-Related Protein Binding to Melanocortin Receptors. 1999 US Biochemistry BICHAW 0033 0006-2960 37 12172 12177 10.1021/bi981082v Determination of Disulfide Structure in Agouti-Related Protein (Agrp) by Stepwise Reduction and Alkylation 1998 10.2210/pdb1hyk/pdb pdb_00001hyk 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 5207.157 AGOUTI RELATED PROTEIN C-TERMINAL DOMAIN AC-AGRP(87-132) 1 syn polymer no no CVRLHESCLGQQVPCCDPCATCYCRFFNAFCYCRKLGTAMNPCSRT CVRLHESCLGQQVPCCDPCATCYCRFFNAFCYCRKLGTAMNPCSRT A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n database_2 pdbx_struct_assembly pdbx_struct_oper_list repository Initial release Version format compliance Version format compliance Database references Derived calculations 1 0 2001-02-07 1 1 2008-04-27 1 2 2011-07-13 1 3 2022-02-23 _database_2.pdbx_DOI _database_2.pdbx_database_accession 2001-02-07 SPRSDE 500 MHz NMR structure of Ac-AGRP(87-132) {referred to as MARP or minimized agouti related protein} RCSB Y RCSB 2001-01-19 REL This sequence is the native sequence for the cystine-rich C-terminal domain of the human agouti-related protein. The N-terminal acetylation at residue 87 (the first residue of the sequence) is non-native and done only to prevent a non-native positively charged amino terminus in the synthetic fragment. Synthesis was by means of standard BOC-based solid-phase peptide synthesis followed by refolding and oxidation of cysteines to cystines. sample STANDARD 2D HOMONUCLEAR TECHNIQUES WERE USED TO ASSIGN SPECTRA ACQUIRED OVER THE TEMPERATURE RANGE 288- 303 K. A SUBSET OF UNAMBIGUOUSLY ASSIGNED NOE PEAKS TAKEN FROM DATA ACQUIRED AT 288 K WITH AN 150 MS MIXING TIME WERE USED IN STRUCTURE CALCULATIONS, AS WERE 34 PHI BACKBONE ANGLE RESTRAINTS DERIVED FROM FITTING OF DQF- COSY CROSSPEAKS. BOTH CARRIER PRESATURATION AND Z- GRADIENT WET TECHNIQUES WERE USED FOR SOLVENT SUPPRESSION. New experiments from 1qu8 are E-COSY at 500 MHz and 150 msec 2D-NOESY at 800 MHz, 288K. see refinement method and details 40 40 2D-NOESY DQF-COSY E-COSY 50mM PHOSPHATE 5.00 1 atm 288.00 K The preliminary structure calculation and restraint quality assessment was performed in DYANA v 1.5, so that out of 200 structures the 20 with the lowest target functions would have target function vaules of < 3.0 square angstroms. The lowest target function structure of this family was then submitted as a pre-folded structure in CNS v. 1.0, and 40 structures calculated under cool (< 288K) simulated annealing and conjugate gradient energy minimization. These calculations were carried out in the presence of experimnetal NOE and J-coupling restraints as well as assigned hydrogen bonds consistent with HX protection. DYANA 1.5: 799 unique NOE's from 800 MHz data, 444 resulting distance restraints after pseudoatom calculation/replacement and removal of NOE's between atoms separated by only two or three bonds. 35 alpha-H to amide-H 3-bond J-coupling constants and 44 alpha-H to beta-H 3-bond J-coupling constants from ECOSY data were also included. Disulfides and seven hydrogen bonds as determinied from surrounding NOE's and HX data were included as pseudo-NOE restraints. CNS 1.0, patch level 0: 504 distance restraints from 800 MHz NOE data, corresponding to the same upper limit restraints as used in the final round of DYANA 1.5 calulations (conversion using AQUA 2.0 in PROCHECK_NMR, and modified lower limit of 1.6 angstroms was imposed on all NOE restraints while keeping upper bounds). Disulfide map was incorporated into the covalent structure of the molecule and thereby strictly enforced in this step. The seven hydrogen bonds were included in a separate restraint file. 34 alpha-H to amide-H 3-bond J-coupling constants (not including CYS-87 amide mesurement) were also included. 40 structures were so calculated and all are deposited here. torsion angle dynamics 10 lowest energy 1.9 MM Ac-AGRP(87-132) (same as 1.9 MM MARP of 1qu8) 50 MM PHOSPHATE BUFFER PH 5.0 (pH is changed from pH=4.2 in 1qu8) A.T.BRUNGER, P.D.ADAMS, G.M.CLORE, W.L.DELANO, P.GROS, R.W.GROSSE-KUNSTLEVE, J.-S.JIANG, J.KUSZEWSKI, M.NILGES, N.S.PANNU, R.J.READ, L.M.RICE, T.SIMONSON, G.L.WARREN refinement CNS 1.0 F. Vosman, D. Iverson, S. Patt, S. Chetham, R. Lasater, P. Hornung, G. Brissey, E. Williams, B. John, C. H. Yoder, B. L. Buckwalter collection VNMR 5.2 M. Kjear, K.V. Andersoen, C. Rischel processing MNMR 940501 T. Xia, C. Bartels data analysis XEASY 1.2 P. Guntert, C. Mumenthaler, T. Herrmann structure solution DYANA 1.5 Laskowski R. A., MacArthur M. W., Moss D. S., Thornton J. M., Rullmann J. A. C. processing PROCHECK 3.4.4 800 Varian UNITYPLUS CYS 1 n 1 CYS 1 A VAL 2 n 2 VAL 2 A ARG 3 n 3 ARG 3 A LEU 4 n 4 LEU 4 A HIS 5 n 5 HIS 5 A GLU 6 n 6 GLU 6 A SER 7 n 7 SER 7 A CYS 8 n 8 CYS 8 A LEU 9 n 9 LEU 9 A GLY 10 n 10 GLY 10 A GLN 11 n 11 GLN 11 A GLN 12 n 12 GLN 12 A VAL 13 n 13 VAL 13 A PRO 14 n 14 PRO 14 A CYS 15 n 15 CYS 15 A CYS 16 n 16 CYS 16 A ASP 17 n 17 ASP 17 A PRO 18 n 18 PRO 18 A CYS 19 n 19 CYS 19 A ALA 20 n 20 ALA 20 A THR 21 n 21 THR 21 A CYS 22 n 22 CYS 22 A TYR 23 n 23 TYR 23 A CYS 24 n 24 CYS 24 A ARG 25 n 25 ARG 25 A PHE 26 n 26 PHE 26 A PHE 27 n 27 PHE 27 A ASN 28 n 28 ASN 28 A ALA 29 n 29 ALA 29 A PHE 30 n 30 PHE 30 A CYS 31 n 31 CYS 31 A TYR 32 n 32 TYR 32 A CYS 33 n 33 CYS 33 A ARG 34 n 34 ARG 34 A LYS 35 n 35 LYS 35 A LEU 36 n 36 LEU 36 A GLY 37 n 37 GLY 37 A THR 38 n 38 THR 38 A ALA 39 n 39 ALA 39 A MET 40 n 40 MET 40 A ASN 41 n 41 ASN 41 A PRO 42 n 42 PRO 42 A CYS 43 n 43 CYS 43 A SER 44 n 44 SER 44 A ARG 45 n 45 ARG 45 A THR 46 n 46 THR 46 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 A N TYR 23 A N TYR 23 A O TYR 32 A O TYR 32 1 A ARG 3 -79.70 -163.56 1 A HIS 5 -155.85 77.69 1 A LEU 9 22.32 99.52 1 A PHE 26 -145.45 -154.76 1 A PHE 27 -55.65 -71.00 1 A ASN 28 -155.19 75.87 1 A ALA 29 -153.09 -61.57 1 A LEU 36 60.61 111.15 1 A ASN 41 -150.26 69.41 1 A CYS 43 -82.29 -118.34 1 A ARG 45 -154.85 66.27 2 A ARG 3 -79.73 -169.36 2 A HIS 5 -154.69 71.84 2 A LEU 9 18.18 98.90 2 A GLN 11 74.89 -31.56 2 A PHE 26 -145.38 -155.22 2 A ASN 28 -156.08 83.44 2 A ALA 29 -150.82 -77.37 2 A LEU 36 58.47 109.01 2 A ASN 41 -150.19 69.41 2 A CYS 43 -81.51 -116.64 3 A ARG 3 -78.57 -166.38 3 A HIS 5 -154.91 68.03 3 A LEU 9 23.70 93.07 3 A GLN 11 74.59 -51.70 3 A GLN 12 -90.55 36.92 3 A ASN 28 -154.17 74.07 3 A ALA 29 -152.06 -60.83 3 A LEU 36 59.74 110.30 3 A ASN 41 -150.47 68.15 3 A CYS 43 -81.80 -116.88 3 A ARG 45 -154.91 82.60 4 A ARG 3 -79.29 -168.12 4 A HIS 5 -153.28 69.61 4 A LEU 9 23.96 91.52 4 A GLN 11 75.26 -52.71 4 A CYS 19 59.00 15.67 4 A PHE 26 -145.06 -156.35 4 A ASN 28 -156.03 80.24 4 A ALA 29 -151.87 -71.72 4 A LEU 36 60.49 110.37 4 A ASN 41 -150.17 65.98 4 A CYS 43 -82.30 -119.34 5 A HIS 5 -155.84 71.11 5 A LEU 9 26.74 93.75 5 A GLN 11 72.29 -3.07 5 A PHE 26 -145.09 -155.06 5 A ASN 28 -156.39 83.66 5 A ALA 29 -150.81 -79.91 5 A LEU 36 58.94 109.39 5 A CYS 43 -82.21 -117.62 5 A ARG 45 -155.26 82.63 6 A ARG 3 -76.68 -163.09 6 A HIS 5 -155.25 52.98 6 A LEU 9 25.25 94.81 6 A PHE 26 -144.53 -155.00 6 A ASN 28 -155.75 79.45 6 A ALA 29 -152.27 -67.92 6 A LEU 36 60.07 110.74 6 A ASN 41 -150.08 71.35 6 A CYS 43 -82.31 -118.10 6 A ARG 45 -155.10 86.24 7 A HIS 5 -86.06 47.51 7 A LEU 9 25.85 84.72 7 A PHE 26 -145.75 -155.77 7 A ASN 28 -156.01 83.54 7 A ALA 29 -150.56 -76.69 7 A LYS 35 -83.60 35.87 7 A LEU 36 54.89 107.40 7 A ASN 41 -150.12 74.59 7 A CYS 43 -82.03 -117.44 7 A ARG 45 -154.94 74.03 8 A ARG 3 -79.51 -166.93 8 A HIS 5 -156.29 70.90 8 A LEU 9 15.57 106.77 8 A CYS 19 59.12 16.10 8 A PHE 26 -146.08 -156.86 8 A ASN 28 -155.09 79.97 8 A ALA 29 -152.10 -70.76 8 A LYS 35 -84.46 35.58 8 A LEU 36 56.88 108.75 8 A ASN 41 -150.17 72.50 8 A CYS 43 -82.59 -119.06 8 A ARG 45 -154.93 78.56 9 A ARG 3 -79.47 -166.78 9 A HIS 5 -155.64 72.53 9 A LEU 9 22.54 82.09 9 A GLN 11 77.34 -38.42 9 A GLN 12 -89.22 34.76 9 A PHE 26 -145.31 -155.02 9 A ASN 28 -156.80 84.29 9 A ALA 29 -149.90 -82.57 9 A LEU 36 56.88 108.29 9 A ASN 41 -150.56 71.71 9 A CYS 43 -82.45 -117.98 9 A ARG 45 -155.13 43.96 10 A ARG 3 -78.71 -165.22 10 A HIS 5 -155.63 65.82 10 A LEU 9 23.42 94.49 10 A GLN 11 74.03 -54.41 10 A PHE 26 -146.21 -158.53 10 A ASN 28 -155.10 78.42 10 A ALA 29 -152.06 -69.57 10 A LEU 36 61.03 111.44 10 A ASN 41 -150.16 67.74 10 A CYS 43 -82.07 -117.22 10 A ARG 45 -154.99 36.98 11 A ARG 3 -78.66 -164.72 11 A HIS 5 -156.66 75.72 11 A LEU 9 15.01 104.36 11 A PHE 26 -145.37 -156.55 11 A ASN 28 -155.00 81.23 11 A ALA 29 -151.31 -73.20 11 A LEU 36 58.73 109.80 11 A ASN 41 -151.85 70.28 11 A CYS 43 -81.76 -116.81 12 A ARG 3 -78.54 -165.04 12 A HIS 5 -154.86 75.33 12 A LEU 9 23.53 94.73 12 A GLN 11 76.48 -23.24 12 A GLN 12 -94.60 32.25 12 A PHE 26 -145.87 -154.83 12 A ASN 28 -155.40 82.79 12 A ALA 29 -151.65 -75.84 12 A LEU 36 60.89 110.26 12 A CYS 43 -82.15 -117.74 12 A ARG 45 -154.84 82.08 13 A ARG 3 -78.04 -163.14 13 A HIS 5 -155.23 81.26 13 A LEU 9 24.58 97.26 13 A GLN 11 57.51 18.99 13 A PHE 26 -142.99 -157.43 13 A ASN 28 -156.30 83.15 13 A ALA 29 -151.01 -80.26 13 A LYS 35 -85.69 30.73 13 A LEU 36 54.78 106.24 13 A ASN 41 -150.31 78.26 13 A CYS 43 -82.24 -117.98 13 A ARG 45 -154.83 78.13 14 A ARG 3 -78.73 -165.16 14 A HIS 5 -154.75 72.46 14 A LEU 9 26.24 94.20 14 A GLN 11 74.81 -11.87 14 A PHE 26 -144.58 -156.18 14 A ASN 28 -156.21 81.69 14 A ALA 29 -152.63 -72.78 14 A LYS 35 -83.94 30.09 14 A LEU 36 55.97 108.05 14 A ASN 41 -150.02 63.82 14 A CYS 43 -82.29 -118.08 14 A ARG 45 -154.98 34.56 15 A ARG 3 -78.42 -168.38 15 A HIS 5 -156.64 74.63 15 A LEU 9 24.56 94.59 15 A CYS 19 57.58 17.35 15 A PHE 26 -145.63 -154.73 15 A ASN 28 -155.95 82.95 15 A ALA 29 -151.78 -74.99 15 A LEU 36 61.47 111.20 15 A ASN 41 -150.81 67.06 15 A CYS 43 -82.87 -120.35 16 A ARG 3 -79.26 -167.25 16 A HIS 5 -156.06 41.31 16 A LEU 9 26.36 95.03 16 A PHE 26 -146.14 -157.10 16 A ASN 28 -155.45 82.12 16 A ALA 29 -151.75 -75.17 16 A LEU 36 59.57 110.14 16 A CYS 43 -82.13 -117.48 16 A ARG 45 -154.96 88.30 17 A ARG 3 -76.34 -165.79 17 A HIS 5 -155.29 72.85 17 A LEU 9 25.13 90.98 17 A GLN 11 77.12 -37.16 17 A GLN 12 -92.57 36.84 17 A PHE 26 -144.60 -156.56 17 A PHE 27 -56.03 -70.11 17 A ASN 28 -154.93 76.42 17 A ALA 29 -152.46 -66.32 17 A LYS 35 -84.88 31.45 17 A LEU 36 57.95 109.24 17 A ASN 41 -150.10 75.37 17 A CYS 43 -82.24 -117.84 17 A ARG 45 -155.14 70.90 18 A ARG 3 -79.61 -167.52 18 A HIS 5 -156.10 71.70 18 A LEU 9 25.26 95.20 18 A GLN 11 73.13 -7.18 18 A PHE 26 -144.08 -155.49 18 A PHE 27 -55.59 -71.45 18 A ASN 28 -155.50 74.06 18 A ALA 29 -152.99 -58.83 18 A LYS 35 -84.42 31.85 18 A LEU 36 55.50 107.48 18 A ASN 41 -150.45 76.67 18 A CYS 43 -82.19 -117.66 18 A ARG 45 -155.17 84.06 19 A LEU 9 29.44 89.13 19 A PHE 26 -143.54 -157.89 19 A PHE 27 -56.20 -70.82 19 A ASN 28 -155.39 68.22 19 A ALA 29 -153.27 -50.57 19 A LYS 35 -83.60 33.12 19 A LEU 36 51.93 104.98 19 A ASN 41 -150.36 78.30 19 A CYS 43 -82.56 -119.46 20 A HIS 5 -154.07 66.74 20 A LEU 9 22.59 93.47 20 A GLN 11 75.32 -47.92 20 A GLN 12 -90.35 36.83 20 A PHE 26 -145.14 -158.72 20 A ASN 28 -154.38 81.85 20 A ALA 29 -152.56 -74.98 20 A LEU 36 58.44 109.07 20 A ASN 41 -150.30 65.84 20 A CYS 43 -81.98 -117.69 20 A ARG 45 -154.92 88.51 21 A HIS 5 -155.31 65.41 21 A LEU 9 22.91 91.42 21 A GLN 11 70.33 -47.14 21 A PHE 26 -144.81 -158.69 21 A ASN 28 -155.44 81.47 21 A ALA 29 -152.39 -75.12 21 A LEU 36 60.87 111.74 21 A ASN 41 -150.36 67.72 21 A CYS 43 -82.29 -118.18 21 A ARG 45 -154.85 56.32 22 A ARG 3 -78.82 -167.18 22 A HIS 5 -155.50 69.59 22 A LEU 9 24.48 95.21 22 A GLN 11 73.55 -5.48 22 A PHE 26 -145.60 -155.75 22 A ASN 28 -154.87 81.53 22 A ALA 29 -151.76 -72.68 22 A LEU 36 60.82 110.94 22 A ASN 41 -150.04 66.90 22 A CYS 43 -82.01 -117.41 22 A ARG 45 -154.66 42.68 23 A ARG 3 -78.64 -166.42 23 A HIS 5 -155.13 70.42 23 A LEU 9 27.07 95.73 23 A PHE 26 -146.68 -156.03 23 A ASN 28 -155.68 83.86 23 A ALA 29 -149.95 -78.00 23 A LEU 36 58.71 109.26 23 A ASN 41 -150.03 75.20 23 A CYS 43 -82.16 -117.42 24 A ARG 3 -78.98 -169.23 24 A HIS 5 -156.07 67.94 24 A LEU 9 23.59 87.09 24 A GLN 11 78.19 -30.50 24 A PHE 26 -143.92 -158.45 24 A ASN 28 -155.16 75.48 24 A ALA 29 -153.09 -63.98 24 A LEU 36 60.80 111.53 24 A ASN 41 -150.11 78.02 24 A CYS 43 -82.50 -118.89 25 A ARG 3 -78.08 -164.37 25 A HIS 5 -154.84 39.42 25 A LEU 9 17.15 99.13 25 A GLN 11 74.43 -48.30 25 A GLN 12 -90.47 36.80 25 A PHE 26 -145.40 -154.25 25 A ASN 28 -156.13 83.50 25 A ALA 29 -151.11 -77.55 25 A LEU 36 61.06 110.89 25 A ASN 41 -150.11 65.22 25 A CYS 43 -81.80 -117.38 25 A ARG 45 -155.06 30.86 26 A ARG 3 -77.71 -162.40 26 A HIS 5 -156.54 75.54 26 A LEU 9 23.83 91.68 26 A GLN 11 75.42 -50.70 26 A PHE 26 -144.32 -154.89 26 A PHE 27 -55.77 -70.37 26 A ASN 28 -155.97 78.11 26 A ALA 29 -152.50 -66.76 26 A LEU 36 57.24 108.31 26 A ASN 41 -150.86 74.39 26 A CYS 43 -81.87 -117.50 26 A ARG 45 -155.16 86.91 27 A ARG 3 -78.25 -164.51 27 A HIS 5 -156.36 75.23 27 A LEU 9 25.79 94.01 27 A PHE 26 -143.85 -158.11 27 A ASN 28 -155.76 80.18 27 A ALA 29 -151.01 -71.38 27 A LEU 36 59.57 110.49 27 A ASN 41 -150.38 66.97 27 A CYS 43 -82.30 -118.48 27 A ARG 45 -155.03 40.97 28 A ARG 3 -79.42 -164.59 28 A HIS 5 -155.46 71.42 28 A LEU 9 92.67 116.94 28 A GLN 11 47.01 28.01 28 A PHE 26 -145.81 -155.78 28 A ASN 28 -156.18 83.02 28 A ALA 29 -151.66 -77.26 28 A LEU 36 59.91 110.89 28 A ASN 41 -150.16 66.31 28 A CYS 43 -81.76 -116.77 28 A ARG 45 -154.86 86.50 29 A ARG 3 -78.14 -168.12 29 A HIS 5 -154.92 71.63 29 A LEU 9 29.33 41.29 29 A GLN 11 71.41 -58.08 29 A PHE 26 -144.82 -158.73 29 A ASN 28 -154.68 78.91 29 A ALA 29 -152.61 -66.68 29 A LEU 36 61.21 111.10 29 A ASN 41 -150.31 61.39 29 A CYS 43 -81.56 -116.35 29 A ARG 45 -154.56 67.79 30 A HIS 5 -154.74 44.83 30 A LEU 9 26.45 93.91 30 A PHE 26 -145.24 -155.00 30 A ASN 28 -155.97 81.48 30 A ALA 29 -152.01 -73.19 30 A LEU 36 60.46 111.38 30 A ASN 41 -150.34 67.00 30 A CYS 43 -82.46 -118.71 30 A ARG 45 -154.86 87.56 31 A HIS 5 -85.35 48.48 31 A LEU 9 27.38 41.96 31 A GLN 11 70.35 -58.73 31 A GLN 12 -91.24 36.02 31 A PHE 26 -145.94 -155.50 31 A ASN 28 -155.97 83.26 31 A ALA 29 -151.20 -74.65 31 A LYS 35 -84.72 40.81 31 A LEU 36 49.98 103.62 31 A ASN 41 -150.35 75.26 31 A CYS 43 -81.60 -117.94 31 A ARG 45 -154.93 85.64 32 A ARG 3 -79.61 -168.26 32 A HIS 5 -155.47 66.72 32 A LEU 9 25.19 96.04 32 A PHE 26 -146.13 -154.57 32 A ASN 28 -155.02 79.33 32 A ALA 29 -153.36 -66.21 32 A LEU 36 60.57 111.12 32 A CYS 43 -81.89 -117.37 33 A ARG 3 -77.99 -169.42 33 A HIS 5 -155.39 72.19 33 A LEU 9 24.37 88.19 33 A GLN 11 76.55 -37.58 33 A GLN 12 -90.01 34.89 33 A PHE 26 -144.43 -154.81 33 A PHE 27 -55.51 -70.58 33 A ASN 28 -155.77 78.21 33 A ALA 29 -152.79 -65.29 33 A LYS 35 -84.61 33.91 33 A LEU 36 57.41 109.20 33 A ASN 41 -150.45 71.93 33 A CYS 43 -82.25 -117.29 33 A ARG 45 -155.24 31.07 34 A ARG 3 -78.70 -164.60 34 A HIS 5 -155.69 46.08 34 A LEU 9 25.67 92.64 34 A GLN 11 73.40 -7.69 34 A PHE 26 -144.02 -154.41 34 A PHE 27 -55.37 -71.54 34 A ASN 28 -155.91 77.32 34 A ALA 29 -152.80 -64.19 34 A LEU 36 57.79 109.17 34 A ASN 41 -150.35 73.21 34 A CYS 43 -82.23 -117.21 35 A ARG 3 -78.59 -165.08 35 A HIS 5 -155.47 75.47 35 A LEU 9 26.18 95.40 35 A PHE 26 -145.26 -155.15 35 A ASN 28 -155.84 80.77 35 A ALA 29 -152.86 -70.74 35 A LYS 35 -83.19 49.71 35 A LEU 36 48.55 103.75 35 A ASN 41 -150.13 79.36 35 A CYS 43 -82.08 -117.55 35 A ARG 45 -154.84 64.05 36 A ARG 3 -78.02 -166.86 36 A HIS 5 -154.78 68.21 36 A LEU 9 22.26 93.36 36 A GLN 11 74.24 -52.25 36 A PHE 26 -144.28 -159.09 36 A ASN 28 -154.97 76.72 36 A ALA 29 -152.49 -65.39 36 A LEU 36 58.55 109.08 36 A ASN 41 -150.07 73.22 36 A CYS 43 -81.41 -116.15 36 A ARG 45 -154.93 77.91 37 A ARG 3 -79.10 -165.09 37 A HIS 5 -154.92 68.90 37 A LEU 9 22.13 95.36 37 A GLN 11 71.06 -55.11 37 A GLN 12 -91.29 38.32 37 A PHE 26 -145.29 -159.07 37 A ASN 28 -155.14 74.17 37 A ALA 29 -152.56 -62.18 37 A LEU 36 61.49 110.81 37 A ASN 41 -150.16 64.66 37 A CYS 43 -81.73 -116.91 37 A ARG 45 -154.98 82.61 38 A ARG 3 -78.12 -162.52 38 A HIS 5 -154.81 47.33 38 A LEU 9 24.25 94.58 38 A PHE 26 -145.94 -155.54 38 A ASN 28 -154.46 80.32 38 A ALA 29 -153.05 -70.29 38 A LEU 36 61.65 111.35 38 A ASN 41 -150.16 73.10 38 A CYS 43 -82.38 -118.10 38 A ARG 45 -154.85 31.89 39 A ARG 3 -78.62 -166.12 39 A HIS 5 -156.33 40.20 39 A LEU 9 25.87 93.10 39 A GLN 11 74.54 -14.20 39 A PHE 26 -142.77 -157.00 39 A ASN 28 -155.91 80.69 39 A ALA 29 -152.10 -70.73 39 A LEU 36 58.97 109.37 39 A ASN 41 -150.33 73.87 39 A CYS 43 -82.17 -117.82 39 A ARG 45 -155.09 60.74 40 A ARG 3 -78.22 -169.47 40 A HIS 5 -154.89 69.87 40 A LEU 9 22.45 95.88 40 A GLN 11 74.45 -6.30 40 A GLN 12 -96.12 34.94 40 A PHE 26 -144.93 -155.97 40 A ASN 28 -155.45 75.57 40 A ALA 29 -152.82 -59.35 40 A LEU 36 61.06 110.72 40 A ASN 41 -150.22 69.00 40 A CYS 43 -81.90 -117.46 AGOUTI-RELATED PROTEIN (87-132) (AC-AGRP(87-132)) 1 N N disulf 2.033 A CYS 1 A SG CYS 1 1_555 A CYS 16 A SG CYS 16 1_555 disulf 2.029 A CYS 8 A SG CYS 8 1_555 A CYS 22 A SG CYS 22 1_555 disulf 2.029 A CYS 15 A SG CYS 15 1_555 A CYS 33 A SG CYS 33 1_555 disulf 2.030 A CYS 19 A SG CYS 19 1_555 A CYS 43 A SG CYS 43 1_555 disulf 2.030 A CYS 24 A SG CYS 24 1_555 A CYS 31 A SG CYS 31 1_555 SIGNALING PROTEIN CYSTEINE RICH; DISULFIDE BOND, ICK, INHIBITOR CYSTINE KNOT, MELANOCORTIN ANTAGONISTS, AGOUTI, AGOUTI-RELATED, AGRP, ENDOGENOUS ANTAGONIST, SIGNALING PROTEIN AGRP_HUMAN UNP 1 87 O00253 CVRLHESCLGQQVPCCDPCATCYCRFFNAFCYCRKLGTAMNPCSRT 87 132 1HYK 1 46 O00253 A 1 1 46 2 anti-parallel A THR 21 A THR 21 A CYS 24 A CYS 24 A CYS 31 A CYS 31 A ARG 34 A ARG 34 1 P 1